1Kawa K.Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.Int J Hematol,2003,78(1):24-31.
2Straathof KC,Bollard CM,Rooney CM,et al.Immunotherapy for Epstein-Barr virus-associated cancers in children.Oncologist,2003,8(1):83-98.
3Sayos J,Wu C,Morra M,et al.The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.Nature,1998,395:462-469.
4Kasahara Y,Yachie A.Cell type specific infection of Epstein-Barr virus(EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.Crit Rev Oncol Hematol,2002,44(3):283-294.
5Taieb A,Plantin P,Du Pasquier P,et al.Gianotti-Crosti syndrome:a study of 26 cases.Br J Dermatol,1986,115(1):49-59.
7Kawa K.Epstein-Barr virus associated disease.Minophagen Med Rev,1999,44:1-13.
8Nakagawa A,Ito M,Saga S.Fatal cytotoxic T-cell proliferation in chronic active Epstein-Barr virus infection in childhood.Am J Clin Pathol,2002,117(2):283-290.
9Davi F,Delecluse HJ,Guiet P,et al.Burkitt-like lymphomas in AIDS patients:characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin' s lymphomas.Burkitt' s Lymphoma Study Group.J Clin Oncol,1998,16(12):3788-3795.
